Enovis unit Companion Animal Health launches CT-RevitL veterinary laser therapy system in US

Enovis Corporation

Enovis Corporation

ENOV

0.00
  • Enovis’ Companion Animal Health unit launched CT-RevitL, a next-generation veterinary photobiomodulation laser therapy system, in the U.S.
  • System uses COMPASS dosing guidance to calibrate treatment delivery, targeting more consistent clinical outcomes across veterinary users.
  • Product is positioned to support recurring, non-drug treatment demand for veterinary practices as laser therapy adoption expands.
  • U.S. availability starts July 13, 2026; international rollout planned in later phases.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enovis Corporation published the original content used to generate this news brief on July 13, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.